Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
1.600
+0.080 (5.26%)
Nov 28, 2025, 4:00 PM EST - Market closed
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $6.01 million as of November 28, 2025. Its market cap has decreased by -6.99% in one year.
Market Cap
6.01M
Enterprise Value
1.37M
1-Year Change
-6.99%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $6.01M, a decrease of -96.89%. That is a compound annual growth rate of -40.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 5.79M | -29.01% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | 103.92M | 39.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 986.24B |
| Johnson & Johnson | 499.06B |
| AbbVie | 404.11B |
| UnitedHealth Group | 299.36B |
| AstraZeneca | 288.24B |
| Merck & Co. | 260.41B |
| Novartis AG | 248.38B |
| Abbott Laboratories | 223.95B |